NEW YORK (GenomeWeb) – Human Longevity and the Cleveland Clinic today announced a broad collaboration to sequence and analyze blood samples from the Cleveland Clinic's GeneBank.
The initial focus of the collaboration will be to perform whole-genome, cancer, and microbiome sequencing with the goal of discovering novel genes and pathways associated with heart disease.
"Using HLI's powerful genomic technologies and analysis tools to better understand the biological basis for disease should enable earlier intervention and better treatments," Human Longevity CEO Craig Venter said in a statement.
Human Longevity is building a database of human genotypes and phenotypes to understand disease and aging. The firm has signed deals giving it access to other biobanks including the TwinsUK Registry and Genentech's patient samples.
Financial and other terms of the agreement were not disclosed.